Antiviral infusion treatment of Ebola virus developed by NIH team
July 30, 2020
A two-decade research journey has led to a treatment that cuts the death rate from Ebola from 70% of untreated people down to nearly 10% for people who get medicine. Nancy Sullivan, Chief of the Biodefense Research Section at the Vaccine Research Center at the National Institutes of Health, has led that journey. She is a finalist for a Service to America Medal in the Science and Environment category.
Publication Type: In the News